Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A practice survey on vasopressor and inotropic drug therapy in Scandinavian intensive care units

View through CrossRef
Background: This practice survey was performed to analyse the indications for use of vasopressor/inotropic drugs, preferred drugs and doses as well as concomitant monitoring and desired haemodynamic target values in Scandinavian ICUs. An internet‐based reporting system was implemented.Methods: A total of 223 ICUs were identified in the Scandinavian countries and invited to participate in a one‐day point‐prevalence study. An internet‐based database was constructed and a practice survey protocol designed to identify haemodynamic monitoring, indications for vasopressor/inotropic drug‐therapy, fluids used for volume loading, pretreatment circulatory state, actual and targeted haemodynamic variables. Patients were eligible for the study if on vasopressor/inotropic drug‐therapy for more than 4 h.Results: A total of 114 ICUs participated. A total of 114 adult patients matched the inclusion criteria. Sixty‐seven per cent of the patients had received vasopressor/inotropic drug‐treatment for >24 h and 32% received more than one drug. Arterial hypotension (92%) and oliguria (50%) were most common indications. Fluid loading prior to therapy was reported in 87% of patients. Dopamine (47%) and noradrenaline (44%) were the most commonly used drugs followed by dobutamine (24%). No other drug exceeded 6%. Non‐catecholamine drugs were rarely used even in cardiac failure patients. Invasive arterial pressure was monitored in 95% of patients, pulmonary artery catheters were used in 19%. Other cardiac output monitoring techniques were used in 8.5% of the patients.Conclusion: Dopamine and noradrenaline seem to be the most commonly used inotropic/vasopressor drugs in Scandinavia. Traditional indications for inotropic/vasopressor support as hypotension and oliguria seem to be most common. Invasive monitoring was used in almost all patients, whereas a limited use of pulmonary artery catheters was noted. The internet‐based reporting system proved to be an efficient tool for data collection.
Title: A practice survey on vasopressor and inotropic drug therapy in Scandinavian intensive care units
Description:
Background: This practice survey was performed to analyse the indications for use of vasopressor/inotropic drugs, preferred drugs and doses as well as concomitant monitoring and desired haemodynamic target values in Scandinavian ICUs.
An internet‐based reporting system was implemented.
Methods: A total of 223 ICUs were identified in the Scandinavian countries and invited to participate in a one‐day point‐prevalence study.
An internet‐based database was constructed and a practice survey protocol designed to identify haemodynamic monitoring, indications for vasopressor/inotropic drug‐therapy, fluids used for volume loading, pretreatment circulatory state, actual and targeted haemodynamic variables.
Patients were eligible for the study if on vasopressor/inotropic drug‐therapy for more than 4 h.
Results: A total of 114 ICUs participated.
A total of 114 adult patients matched the inclusion criteria.
Sixty‐seven per cent of the patients had received vasopressor/inotropic drug‐treatment for >24 h and 32% received more than one drug.
Arterial hypotension (92%) and oliguria (50%) were most common indications.
Fluid loading prior to therapy was reported in 87% of patients.
Dopamine (47%) and noradrenaline (44%) were the most commonly used drugs followed by dobutamine (24%).
No other drug exceeded 6%.
Non‐catecholamine drugs were rarely used even in cardiac failure patients.
Invasive arterial pressure was monitored in 95% of patients, pulmonary artery catheters were used in 19%.
Other cardiac output monitoring techniques were used in 8.
5% of the patients.
Conclusion: Dopamine and noradrenaline seem to be the most commonly used inotropic/vasopressor drugs in Scandinavia.
Traditional indications for inotropic/vasopressor support as hypotension and oliguria seem to be most common.
Invasive monitoring was used in almost all patients, whereas a limited use of pulmonary artery catheters was noted.
The internet‐based reporting system proved to be an efficient tool for data collection.

Related Results

Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Predicting Need for Vasopressors in the Intensive Care Unit Using an Attention Based Deep Learning Model
Predicting Need for Vasopressors in the Intensive Care Unit Using an Attention Based Deep Learning Model
Abstract BackgroundPrevious models on prediction of shock mostly focused on septic shock and often required laboratory results in their models. Database analyses often repo...
Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia
Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia
Introduction: Type 2 diabetes mellitus patients with hypertension are at high risk of drug therapy problems since they are subject to receive multiple drug therapies due to comorbi...
667 Increased Access to Burn Therapy Services in Burn Urgent Care Clinic
667 Increased Access to Burn Therapy Services in Burn Urgent Care Clinic
Abstract Introduction Burn therapy is considered a key service throughout the continuum of care for burn survivors to promote fu...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
OR-1896 increases force of contraction in the isolated human atrium
OR-1896 increases force of contraction in the isolated human atrium
Abstract OR-1896 ((R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl) phenyl)-acetamide) is the main active metabolite of levosimendan. However, nobody has reported ...
Development and Psychometric Validation of the Empathy Fatigue Scale (EFS‐HP) for Healthcare Professionals in Critical Care Settings
Development and Psychometric Validation of the Empathy Fatigue Scale (EFS‐HP) for Healthcare Professionals in Critical Care Settings
ABSTRACTBackgroundEmpathy fatigue represents a significant concern among healthcare professionals working in critical care settings, including intensive care units, emergency depar...

Back to Top